Mar 22, 2023
Starpharma presents at ASX Small and Mid-Cap Conference (ASX Announcement)
Melbourne, Australia; 22 March 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces that Starpharma CEO Dr Jackie Fairley will present a brief overview of the Company at the ASX Small and Mid-Cap Conference today at 11:00am AEDT. The Conference showcases selected ASX-listed companies to Australian investors.
Starpharma’s presentation will include a brief overview of its portfolio, key value drivers and outlook, including:
- the Company’s clinical-stage DEP® programs;
- multiple DEP® partnerships with global companies;
- new AZD0466 data, including preclinical data in small cell lung cancer (SCLC) and clinical data in Phase 1 solid-tumour patients, which will be presented by AstraZeneca at the upcoming American Association for Cancer Research Annual Meeting in April 2023; and
- on-market products including VIRALEZE™ and VivaGel®
Investors are invited to join the Conference by registering online at: https://www2.asx.com.au/
The presentation can be viewed here.
This contains certain forward-looking statements.